HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$24.64
Day range
$24.21 - $25.36
Year range
$13.40 - $28.35
Market cap
4.16B USD
Avg Volume
1.55M
P/E ratio
10.67
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 283.99M | 9.39% |
Operating expense | 155.62M | 19.63% |
Net income | 273.57M | 90.32% |
Net profit margin | 96.33 | 73.98% |
Earnings per share | 0.14 | -84.01% |
EBITDA | 20.34M | 66.70% |
Effective tax rate | -939.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 819.69M | 8.43% |
Total assets | 1.56B | 31.69% |
Total liabilities | 336.80M | -25.97% |
Total equity | 1.23B | — |
Shares outstanding | 169.34M | — |
Price to book | 3.40 | — |
Return on assets | 3.00% | — |
Return on capital | 3.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 273.57M | 90.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
796
